查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575300

双丙戊酸钠市场：按产品类型、应用、最终用户、分销管道 - 2025-2030 年全球预测

Divalproex Sodium Market by Product Type (Delayed-Release Tablets, Extended-Release Tablets, Immediate-Release Tablets), Application (Bipolar Disorder, Epilepsy, Migraine), End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年双丙戊酸钠市值为23.4亿美元，预计2024年将达24.7亿美元，复合年增长率为6.19%，预计到2030年将达到35.7亿美元。

双丙戊酸钠是一种抗惊厥药，主要用于治疗惊厥性疾病、躁郁症和预防偏头痛，其市场范围充满活力，遍及整个製药行业。对双丙戊酸钠的需求在于其作为神经和精神疾病的重要治疗选择的既定作用，透过稳定情绪和预防偏头痛来改善患者的生活质量，并提供了重要的应用优势。最终用途多种多样，包括医院、诊所和疗养院，事实证明在各种医疗保健环境中已被广泛接受了。主要成长动力包括神经系统疾病盛行率上升、精神疾病意识和诊断的提高以及扩大治疗应用的研究进展。个人化医疗的日益增长以及人工智慧在药物开发中的整合带来了最新的潜在机会，这可以增强患者的针对性并支持双丙戊酸钠的新配方。抓住这些机会的治疗方法包括投资个人化治疗解决方案以及与科技公司建立策略联盟以利用人工智慧功能。儘管潜力巨大，但该市场仍面临副作用、严格的监管要求以及学名药竞争等限制和挑战，这可能会阻碍成长前景。此外，主要市场的医疗保健政策不确定性可能会影响市场稳定性。创新和研究可能集中在开发提高患者依从性的剂型，例如缓释性製剂，并探索提高疗效同时减少副作用的组合疗法。此外，透过研究其机制，可能会发现其在其他精神和神经疾病中的应用。随着市场竞争激烈，几家主要企业投资研发以实现产品差异化，创新和成本效率措施对于持续的业务成长和竞争力变得尤为重要。

主要市场统计
基准年[2023] 23.4亿美元
预测年份 [2024] 24.7亿美元
预测年份 [2030] 35.7亿美元
复合年增长率（%） 6.19%

市场动态：揭示快速发展的双丙戊酸钠市场的关键市场洞察

双丙戊酸钠市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 医学研究进展提高了对双极性情感障碍的了解和双丙戊酸钠的治疗效果
    • 政府支持心理健康治疗的措施促进了双丙戊酸钠市场的成长
    • 由于已开发国家和开发中国家医疗费用的上涨，改善双丙戊酸钠的获取
    • 透过开发双丙戊酸钠新配方来提高患者依从性并减少副作用
  • 市场限制因素
    • 供应链中断和原材料短缺影响生产计划和市场供应
    • 广泛的临床测试要求延长了新配方和创新产品的上市时间
  • 市场机会
    • 双丙戊酸钠缓释缓释性的创新可提高患者依从性和治疗结果
    • 开发双丙戊酸钠组合药物增强多症状神经系统疾病的治疗效果
    • 透过个人化双丙戊酸钠剂量和给药方案解决服务不足的患者群体问题
  • 市场挑战
    • 由于人们越来越担心双丙戊酸钠的潜在副作用和安全性，采用有限
    • 双丙戊酸钠市场维持供应链效率和管理原料短缺的挑战

波特的五力：驾驭双丙戊酸钠市场的策略工具

波特的五力架构是了解双丙戊酸钠市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解双丙戊酸钠市场的外部影响

外部宏观环境因素在塑造双丙戊酸钠市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解双丙戊酸钠市场的竞争状况

对双丙戊酸钠市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵双丙戊酸钠市场供应商的绩效评估

FPNV定位矩阵是评估双丙戊酸钠市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了双丙戊酸钠市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对双丙戊酸钠市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 医学研究的进步提高了对双极性情感障碍的认识和治疗效果。双丙戊酸钠
      • 政府支持心理健康治疗的倡议推动了 Gival Pro Extra 市场的成长
      • 已开发国家和新兴国家不断上涨的医疗费用改善了获得医疗服务的机会
      • 开发双丙戊酸钠新配方以提高患者依从性并减少副作用
    • 抑制因素
      • 供应链中断和原材料短缺影响生产计划和市场供应
      • 广泛的临床试验要求延长了新配方和创新的上市时间
    • 机会
      • 双丙戊酸钠缓释性的创新可提高患者依从性和治疗结果
      • 开发双丙戊酸钠药物组合以提高治疗多症状神经系统疾病的功效
      • 透过个人化双丙戊酸钠剂量和给药方案瞄准服务不足的患者群体
    • 任务
      • 人们越来越担心双丙戊酸钠的潜在副作用和安全性，限制了其采用
      • 双丙戊酸钠市场维持供应链效率和管理原料短缺的挑战
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章双丙戊酸钠市场：依产品类型

  • 缓释片剂
    • 品牌名称
    • 非专利的
  • 缓释片
    • 品牌名称
    • 非专利的
  • 速效锭剂
    • 品牌名称
    • 非专利的
  • 将胶囊撒开
    • 品牌名称
    • 非专利的

第七章双丙戊酸钠市场：依应用分类

  • 躁郁症
    • 急性躁郁症
    • 辅助性治疗
    • 维持治疗
  • 癫痫
    • 辅助性治疗
    • 单一疗法
  • 偏头痛
    • 预防

第 8 章 双丙戊酸钠市场：依最终用户分类

  • 诊所
    • 普通科诊所
    • 专科诊所
  • 居家护理
    • 看护者管理
    • 病患管理
  • 医院
    • 住院病人
    • 门诊

第 9 章 双丙戊酸钠市场：按分销管道

  • 医院药房
  • 网路药房
  • 零售药房

第十章美洲双丙戊酸钠市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区双丙戊酸钠市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲双丙戊酸钠市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C0549

The Divalproex Sodium Market was valued at USD 2.34 billion in 2023, expected to reach USD 2.47 billion in 2024, and is projected to grow at a CAGR of 6.19%, to USD 3.57 billion by 2030.

Divalproex Sodium, an anticonvulsant medication primarily used for treating seizure disorders, bipolar disorder, and to prevent migraines, has a dynamic market scope extending across the pharmaceutical industry. The necessity of Divalproex Sodium lies in its established role as an essential treatment option for neurological and psychiatric conditions, offering significant application benefits by stabilizing mood and preventing migraines, thus improving patient quality of life. The end-use scope encompasses hospitals, clinics, and nursing homes, attesting to its broad acceptance in various healthcare settings. Key growth drivers include rising prevalence of neurological disorders, increased awareness and diagnosis of psychiatric conditions, and ongoing research into its expanded therapeutic applications. Latest potential opportunities arise from the growing trend of personalized medicine and the integration of AI in drug development, which could enhance patient targeting and support novel formulations of Divalproex Sodium. Recommendations to seize these opportunities include investing in personalized treatment solutions and strategic partnerships with technology firms to leverage AI capabilities. Despite its potential, the market faces limitations and challenges such as side-effect profiles, stringent regulatory requirements, and the competition from generic drugs, which could hinder growth prospects. Further, uncertainty in healthcare policies across major markets may affect market stability. Innovation and research could pivot towards the development of dosage forms that enhance patient adherence, such as extended-release formulations, and exploring combinatorial therapies that increase efficacy while reducing adverse effects. Additionally, research into its mechanisms could uncover applications in other psychiatric or neurological disorders. The nature of the market is highly competitive with several key players investing in R&D to ensure product differentiation, presenting an environment where innovation and cost-efficiency measures are particularly critical for sustained business growth and gaining a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 2.34 billion
Estimated Year [2024] USD 2.47 billion
Forecast Year [2030] USD 3.57 billion
CAGR (%) 6.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Divalproex Sodium Market

The Divalproex Sodium Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Advancements in medical research improving understanding of bipolar disorder and treatment effectiveness with divalproex sodium
    • Government initiatives supporting mental health treatment boosting divalproex sodium market growth
    • Increasing healthcare expenditure in developed and developing countries enhancing access to divalproex sodium
    • Developing novel formulations of divalproex sodium providing better patient compliance and reduced side effects
  • Market Restraints
    • Supply chain disruptions and raw material shortages impacting production timelines and market supply
    • Extensive clinical trial requirements elongating time to market for new formulations and innovations
  • Market Opportunities
    • Innovation in extended-release formulations of divalproex sodium to improve patient compliance and therapeutic outcomes
    • Developing divalproex sodium drug combinations for enhanced efficacy in treating multi-symptomatic neurological conditions
    • Targeting underserved patient demographics through personalized divalproex sodium dosing and administration schedules
  • Market Challenges
    • Increasing concern over potential side effects and safety profile of divalproex sodium limiting its adoption
    • Challenges in maintaining supply chain efficiency and managing raw material shortages in the divalproex sodium market

Porter's Five Forces: A Strategic Tool for Navigating the Divalproex Sodium Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Divalproex Sodium Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Divalproex Sodium Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Divalproex Sodium Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Divalproex Sodium Market

A detailed market share analysis in the Divalproex Sodium Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Divalproex Sodium Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Divalproex Sodium Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Divalproex Sodium Market

A strategic analysis of the Divalproex Sodium Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Divalproex Sodium Market, highlighting leading vendors and their innovative profiles. These include Allergan plc, Amgen Inc., AstraZeneca, Avkare Inc., Boehringer Ingelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Hikma Pharmaceuticals, Intas Pharmaceuticals, Janssen Pharmaceuticals, Jubilant Life Sciences, Merck & Co., Inc., Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi S.A., Sigmapharm Laboratories, Takeda Pharmaceutical Company Limited, and UCB S.A..

Market Segmentation & Coverage

This research report categorizes the Divalproex Sodium Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Delayed-Release Tablets, Extended-Release Tablets, Immediate-Release Tablets, and Sprinkle Capsules. The Delayed-Release Tablets is further studied across Brand Name and Generic. The Extended-Release Tablets is further studied across Brand Name and Generic. The Immediate-Release Tablets is further studied across Brand Name and Generic. The Sprinkle Capsules is further studied across Brand Name and Generic.
  • Based on Application, market is studied across Bipolar Disorder, Epilepsy, and Migraine. The Bipolar Disorder is further studied across Acute Mania, Adjunctive Therapy, and Maintenance Treatment. The Epilepsy is further studied across Adjunctive Therapy and Monotherapy. The Migraine is further studied across Prophylaxis.
  • Based on End User, market is studied across Clinics, Homecare, and Hospitals. The Clinics is further studied across General Clinics and Specialty Clinics. The Homecare is further studied across Caregiver Administered and Patient Administered. The Hospitals is further studied across Inpatient and Outpatient.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Advancements in medical research improving understanding of bipolar disorder and treatment effectiveness with divalproex sodium
      • 5.1.1.2. Government initiatives supporting mental health treatment boosting divalproex sodium market growth
      • 5.1.1.3. Increasing healthcare expenditure in developed and developing countries enhancing access to divalproex sodium
      • 5.1.1.4. Developing novel formulations of divalproex sodium providing better patient compliance and reduced side effects
    • 5.1.2. Restraints
      • 5.1.2.1. Supply chain disruptions and raw material shortages impacting production timelines and market supply
      • 5.1.2.2. Extensive clinical trial requirements elongating time to market for new formulations and innovations
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovation in extended-release formulations of divalproex sodium to improve patient compliance and therapeutic outcomes
      • 5.1.3.2. Developing divalproex sodium drug combinations for enhanced efficacy in treating multi-symptomatic neurological conditions
      • 5.1.3.3. Targeting underserved patient demographics through personalized divalproex sodium dosing and administration schedules
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing concern over potential side effects and safety profile of divalproex sodium limiting its adoption
      • 5.1.4.2. Challenges in maintaining supply chain efficiency and managing raw material shortages in the divalproex sodium market
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Divalproex Sodium Market, by Product Type

  • 6.1. Introduction
  • 6.2. Delayed-Release Tablets
    • 6.2.1. Brand Name
    • 6.2.2. Generic
  • 6.3. Extended-Release Tablets
    • 6.3.1. Brand Name
    • 6.3.2. Generic
  • 6.4. Immediate-Release Tablets
    • 6.4.1. Brand Name
    • 6.4.2. Generic
  • 6.5. Sprinkle Capsules
    • 6.5.1. Brand Name
    • 6.5.2. Generic

7. Divalproex Sodium Market, by Application

  • 7.1. Introduction
  • 7.2. Bipolar Disorder
    • 7.2.1. Acute Mania
    • 7.2.2. Adjunctive Therapy
    • 7.2.3. Maintenance Treatment
  • 7.3. Epilepsy
    • 7.3.1. Adjunctive Therapy
    • 7.3.2. Monotherapy
  • 7.4. Migraine
    • 7.4.1. Prophylaxis

8. Divalproex Sodium Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
    • 8.2.1. General Clinics
    • 8.2.2. Specialty Clinics
  • 8.3. Homecare
    • 8.3.1. Caregiver Administered
    • 8.3.2. Patient Administered
  • 8.4. Hospitals
    • 8.4.1. Inpatient
    • 8.4.2. Outpatient

9. Divalproex Sodium Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Americas Divalproex Sodium Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Divalproex Sodium Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Divalproex Sodium Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allergan plc
  • 2. Amgen Inc.
  • 3. AstraZeneca
  • 4. Avkare Inc.
  • 5. Boehringer Ingelheim
  • 6. Bristol-Myers Squibb Company
  • 7. Eli Lilly and Company
  • 8. GlaxoSmithKline plc
  • 9. Hikma Pharmaceuticals
  • 10. Intas Pharmaceuticals
  • 11. Janssen Pharmaceuticals
  • 12. Jubilant Life Sciences
  • 13. Merck & Co., Inc.
  • 14. Novartis AG
  • 15. Pfizer Inc.
  • 16. Roche Holding AG
  • 17. Sanofi S.A.
  • 18. Sigmapharm Laboratories
  • 19. Takeda Pharmaceutical Company Limited
  • 20. UCB S.A.

LIST OF FIGURES

  • FIGURE 1. DIVALPROEX SODIUM MARKET RESEARCH PROCESS
  • FIGURE 2. DIVALPROEX SODIUM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIVALPROEX SODIUM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DIVALPROEX SODIUM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DIVALPROEX SODIUM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIVALPROEX SODIUM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIVALPROEX SODIUM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIVALPROEX SODIUM MARKET DYNAMICS
  • TABLE 7. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY BRAND NAME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY BRAND NAME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY BRAND NAME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY BRAND NAME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY ACUTE MANIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY ADJUNCTIVE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY MAINTENANCE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY ADJUNCTIVE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY CAREGIVER ADMINISTERED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY PATIENT ADMINISTERED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY INPATIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 166. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 168. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 178. CHINA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. CHINA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 180. CHINA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 181. CHINA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 182. CHINA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 191. INDIA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 192. INDIA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. INDIA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 194. INDIA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 195. INDIA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 196. INDIA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 204. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 205. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 206. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 208. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 209. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 210. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 218. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 219. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 220. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 222. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 223. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 224. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 228. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 230. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 232. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 233. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 234. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 236. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 237. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 238. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 242. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 244. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 246. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 248. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 250. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 252. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 255. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 256. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 257. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 258. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 260. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 261. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 262. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 264. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 265. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 266. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 269. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 270. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 281. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 283. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 284. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 285. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 286. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 288. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 289. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 290. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 291. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 292. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 293. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 294. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 295. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 297. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 298. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 299. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 300. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 302. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 303. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 304. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 305. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 306. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 307. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 308. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 309. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 311. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 312. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 313. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 314. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 316. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 317. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 318. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 319. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 320. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 321. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 322. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 325. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 326. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 332. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 333. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 334. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 335. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 336. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 337. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 338. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 339. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 340. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 341. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 342. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 343. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 344. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 345. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 346. DENMARK DIVALPROEX SODIUM M